← Back to Analyst Consensus 
IOBT Hold
IO Biotech, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jan 26, 2026 | Piper Sandler | downgrade | Overweight → Neutral | $0.5 | 54% |
| Oct 22, 2025 | Piper Sandler | maintain | Overweight → Overweight | $3 | 54% |
| Sep 30, 2025 | TD Cowen | downgrade | Buy → Hold | $0 | 54% |
| Sep 29, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Aug 12, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $4 | 54% |
| Apr 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Mar 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Sep 16, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $6 | 54% |
| Sep 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Sep 3, 2024 | Piper Sandler | maintain | Overweight → Overweight | $10 | 54% |
| Sep 3, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $4 | 54% |
| Sep 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| May 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Mar 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Sep 28, 2023 | Piper Sandler | initiate | — → Overweight | $10 | 54% |
| Sep 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Aug 15, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $7 | 54% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Mar 15, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| Jan 24, 2023 | Morgan Stanley | maintain | — → Overweight | $11 | 54% |
| Nov 21, 2022 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Nov 30, 2021 | Morgan Stanley | initiate | — → Overweight | $21 | 54% |
| Nov 30, 2021 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Nov 30, 2021 | Jefferies | initiate | — → Buy | $20 | 52% |
Price Target Trend
Apr 25, 2026 Latest: $2.18 Jun 4, 2026
EPS Estimates
0q $-0.14
Lo: $-0.14 Hi: $-0.14
1 analysts ▲1
+1q —
0y $-0.88
Lo: $-0.88 Hi: $-0.88
1 analysts ▲1
+1y $-0.36
Lo: $-0.36 Hi: $-0.36
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days